Top compounds associated with response to CTD-2331H12.8


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.1
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.06 0.1
mRNA CIL55 CTRPv2 pan-cancer AAC 0.1 0.1
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.07 0.1
mRNA pluripotin CTRPv2 pan-cancer AAC -0.06 0.1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA PF-184 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.06 0.1
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.06 0.1
Download CSV